Kaynes Technology India Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• Internet of Things ("IoT") solutions enabled integrated electronics manufacturing player with end-to-end capabilities across the Electronics System Design and Manufacturing spectrum.
• Diversified business model with portfolio having applications across industry verticals
• Long-standing relationships with marquee customer base
• Global certifications for each industry vertical catered to and multiple facilities across India with advanced infrastructure
• Strong supply chain and sourcing network

• Its business is dependent on the sale of products of the company customers and the loss of one or more such customers or a reduction in demandfor their products could adversely affect its business, results of operations, financial condition and cash flows.
• The company do not have firm commitment agreements with all of its customers. If the company customers choose not to source their requirements from it, the company business and results of operations may be adversely affected.
• If the company customers do not outsource manufacturing of the products, or if there is a downward trend in the original equipment manufacturers ("OEMs") / original design manufacturing ("ODMs") business and/or demand for our internet of things ("IoT") solutions it could have an adverse effect on its business, results of operations, financial condition and cash flows.
• The company relies on the continued operations of its manufacturing facilities and any slowdown, shutdown or disruption in its manufacturing facilities may be caused by natural and other disasters causing unforeseen damages which may lead to disruptions in its business and operations could have an adverse effect on its business, results of operations, financial condition and cash flows.
• Its proposed capacity expansion plans relating to the company manufacturing facilities are subject to the risk of unanticipated delays in implementation and cost overruns.

• Focus on full product / box build capabilities
• Leverage its research and development capabilities to continue to diversify product portfolio and provide value-added services
• Focus on expansion across each vertical to capitalize on industry opportunity
• Continue to expand its customer base to focus on large customers
• Expand manufacturing capacity at its existing facilities and set-up additional strategically located facilities